STOCKWATCH
·
Pharmaceuticals
Quarterly Result19 Jul 2025, 04:03 am

Kerala Ayurveda Reports 44% Revenue Growth in Q1 FY26, Aims for 50% Topline Growth in 2026

AI Summary

Kerala Ayurveda Ltd (KAL) has reported a 44% year-over-year (YOY) revenue growth in Q1 FY26, with adjusted EBITDA at Rs.6.4 Crs. The company is planning to double its growth rate to 50% in 2026, backed by significant investments in digital and health service businesses, marketing, technology, and international expansion. The Q1 FY26 revenue was Rs.39.8 Crs, with a 17% core operating revenue growth. The company's digital business in India grew by 44%, while the US Wellness Center business saw a 90% growth. The US Academy business delivered a 20% organic growth. The Singapore Clinics business was fully integrated, adding Rs.1.2 Crs to the topline. The company is also focusing on enhancing its digital and e-commerce expansion, global partnerships, and expansion of HS clinics.

Key Highlights

  • KAL reports 44% revenue growth in Q1 FY26
  • Plans to double growth rate to 50% in 2026
  • Significant investments in digital and health service businesses
  • 17% core operating revenue growth in Q1 FY26
  • 44% growth in India digital business and 90% growth in US Wellness Center business
KERALAYUR
Pharmaceuticals
KERALA AYURVEDA LTD.

Price Impact